Related references
Note: Only part of the references are listed.One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease
Joao Tome-Carneiro et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes
Pedram Kazemian et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Association Between Plasma High-Molecular-Weight Adiponectin and Coronary Plaque Characteristics Assessed by Computed Tomography Angiography in Conditions of Visceral Adipose Accumulation
Eiji Kunita et al.
CIRCULATION JOURNAL (2012)
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
Ph Gabriel Steg et al.
EUROPEAN HEART JOURNAL (2012)
A Dietary Resveratrol-Rich Grape Extract Prevents the Developing of Atherosclerotic Lesions in the Aorta of Pigs Fed an Atherogenic Diet
Maria Azorin-Ortuno et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Effects of long-term consumption of low doses of resveratrol on diet-induced mild hypercholesterolemia in pigs: a transcriptomic approach to disease prevention
Maria Azorin-Ortuno et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial
Joao Tome-Carneiro et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
A Tale of Coronary Artery Disease and Myocardial Infarction
Elizabeth G. Nabel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Jayesh Kumar Bhatt et al.
NUTRITION RESEARCH (2012)
Resveratrol in cardiovascular health and disease
Goran Petrovski et al.
RESVERATROL AND HEALTH (2011)
Clinical trials of resveratrol
Ketan R. Patel et al.
RESVERATROL AND HEALTH (2011)
Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes Findings From the Look AHEAD Study
L. Maria Belalcazar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients
Pal Brasnyo et al.
BRITISH JOURNAL OF NUTRITION (2011)
Resveratrol Shows Vasoprotective Effect Reducing Oxidative Stress Without Affecting Metabolic Disturbances in Insulin-dependent Diabetes of Rabbits
Fatma Akar et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Adiponectin and Vulnerable Atherosclerotic Plaques
Ailin Barseghian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association
Sidney C. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Metabolites and tissue distribution of resveratrol in the pig
Maria Azorin-Ortuno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Ole Vang et al.
PLOS ONE (2011)
Impact of Comprehensive and Intensive Treatment of Risk Factors Concerning Cardiovascular Mortality in Secondary Prevention: MIRVAS Study
Miguel A. Moreno-Palanco et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2011)
Epicardial Adipokines in Obesity and Coronary Artery Disease Induce Atherogenic Changes in Monocytes and Endothelial Cells
Kalypso Karastergiou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Clinical implications of inflammation for cardiovascular primary prevention
Peter Libby et al.
EUROPEAN HEART JOURNAL (2010)
Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants
J. Olholm et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
The Protective Effect of the Mediterranean Diet: Focus on Cancer and Cardiovascular Risk
Ernest K. J. Pauwels
MEDICAL PRINCIPLES AND PRACTICE (2010)
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
Leonor Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Resveratrol Supplementation Gender Independently Improves Endothelial Reactivity and Suppresses Superoxide Production in Healthy Rats
Selen Soylemez et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: Impact on plasma adiponectin level
Kuei-Chuan Chan et al.
CLINICAL CARDIOLOGY (2008)
Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention
Weidong Zhu et al.
CLINICAL SCIENCE (2008)
Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population:: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort
Raul Zamora-Ros et al.
BRITISH JOURNAL OF NUTRITION (2008)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine
Ulrik Stervbo et al.
FOOD CHEMISTRY (2007)
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
Erdal Cavusoglu et al.
EUROPEAN HEART JOURNAL (2006)
Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function
ZY Lin et al.
CIRCULATION RESEARCH (2005)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction
NK Kaba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Implications of plasma concentrations of adiponectin in patients with coronary artery disease
Y Nakamura et al.
HEART (2004)
T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions
M Benagiano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inflammation meets oxidation: NF-kappa B as a mediator of initial lesion development in atherosclerosis
O Kutuk et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Postharvest induction modeling method using UV irradiation pulses for obtaining resveratrol-enriched table grapes:: A new functional fruit?
E Cantos et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
CREB-binding protein and p300 in transcriptional regulation
N Vo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease.
HP Kohler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
